EverSource Wealth Advisors’s Ventyx Biosciences VTYX Stock Holding History

EverSource Wealth Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$361	–	4511
2025 Q4	$361	Sell	40 -90	-69%	-$673	﹤0.01%	3935
2025 Q3	$404	Sell	130 -1,911	-94%	-$5.06K	﹤0.01%	4001
2025 Q2	$4.37K	Buy	2,041 +1,654	+427%	+$2.67K	﹤0.01%	3217
2025 Q1	$445	Buy	+387	New	+$664	﹤0.01%	3496
2024 Q1	–	Sell	-382	Closed	-$944	–	3002
2023 Q4	$944	Buy	+382	New	+$3.63K	﹤0.01%	2416

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors's VTYX Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 40 shares — an estimated $361 sold.

EverSource Wealth Advisors first reported a position in VTYX in Q4 2023 and held it in 5 quarters. The position peaked at $4.37K in Q2 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

EverSource Wealth Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 40 Ventyx Biosciences shares in Q1 2026, an estimated $361.
EverSource Wealth Advisors first reported a position in Ventyx Biosciences in Q4 2023 and held it in 5 quarters.
EverSource Wealth Advisors's Ventyx Biosciences position peaked at $4.37K in Q2 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.